Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology | Hematology
Neutropenia Clinical Trials
A listing of Neutropenia medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.
Arizona
Glendale : Arizona Center for Cancer Care
Phase 2 Study of HM10460A or Pegfilgrastim Use for the Management of Neutropenia in Breast Cancer Patients
Scottdale : Desert Springs Cancer Care
Phase 2 Study of HM10460A or Pegfilgrastim Use for the Management of Neutropenia in Breast Cancer Patients
Arkansas
Jonesboro : Sandoz Investigational Site
Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-Filgrastim
California
Corona : Sandoz Investigational Site
Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-Filgrastim
Fresno : California Cancer Associates for Research and Excellence
Phase 2 Study of HM10460A or Pegfilgrastim Use for the Management of Neutropenia in Breast Cancer Patients
Highland : Beaver Medical Group
Phase 2 Study of HM10460A or Pegfilgrastim Use for the Management of Neutropenia in Breast Cancer Patients
Orange : Hematology Oncology Medical Group
Phase 2 Study of HM10460A or Pegfilgrastim Use for the Management of Neutropenia in Breast Cancer Patients
Florida
Boynton Beach : Thomas Niederman, M.D., Ph.D
Phase 2 Study of HM10460A or Pegfilgrastim Use for the Management of Neutropenia in Breast Cancer Patients
Kentucky
Mt Sterling : Sandoz Investigational Site
Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-Filgrastim
Maryland
Bethesda : National Institutes of Health Clinical Center, 9000 Rockville Pike
Clofarabine Followed By Lenalidomide for High-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia
Michigan
Detroit : Sandoz Investigational Site
Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-Filgrastim
New York
New York : Memorial Sloan-Kettering Cancer Center
Posaconazole Versus Micafungin for Prophylaxis Against Invasive Fungal Infections During Neutropenia in Patients Undergoing Chemotherapy for Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia or Myelodysplastic Syndrome
Rochester : University of Rochester Medical Center
Daptomycin Versus Placebo in Patients With Neutropenia and Fever
North Dakota
Bismarck : St. Alexius Medical Center
A study for patients with breast cancer who are eligible for chemotherapy. Neulasta® will also be used in this study as a comparator to the investigational medication for the treatment of Neutropenia
View More »
Bismarck : Sandoz Investigational Site
Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-Filgrastim
Oregon
Eugene : Sandoz Investigational Site
Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-Filgrastim
Tennessee
Germantown : Sandoz Investigational Site
Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-Filgrastim
Virginia
Newport News : Sandoz Investigational Site
Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-Filgrastim
Brazil
Curitiba : Investigational Site Number 004
Study of Cabazitaxel Combined With Prednisone and Prophylaxis of Neutropenia Complications in the Treatment of Patients With Metastatic Castration-resistant Prostate Cancer
Porto Alegre : Investigational Site Number 005
Study of Cabazitaxel Combined With Prednisone and Prophylaxis of Neutropenia Complications in the Treatment of Patients With Metastatic Castration-resistant Prostate Cancer
Santo Andre : Investigational Site Number 001
Study of Cabazitaxel Combined With Prednisone and Prophylaxis of Neutropenia Complications in the Treatment of Patients With Metastatic Castration-resistant Prostate Cancer
São Paulo : Investigational Site Number 002
Study of Cabazitaxel Combined With Prednisone and Prophylaxis of Neutropenia Complications in the Treatment of Patients With Metastatic Castration-resistant Prostate Cancer
China
Beijing : Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Pharmacokinetics and Pharmacodynamics Study of Pegfilgrastim in Chemotherapy Patients
Shanghai : Shanghai Pulmonary Hospital
A Study of Pegylated rhG-CSF as Support to Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy Receiving Chemotherapy
Czech Republic
Ves pod Plesi 110 : Insitut Onkologie a Rehabilitaca na Plesi
Phase III Study Comparing the Efficacy and Safety of EP2006 and Filgrastim
Znojmo : Nemocnice Znojmo
Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor
France
Paris : Hôpital Européen Georges Pompidou - Service Oncologie Médicale
Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor
Germany
Hamburg : Universitaetsklinik Hamburg-Eppendorf, Med. Klinik II Onkologie, Haematologie
Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor
Hungary
Nyiregyhaza : Josa Andras Oktato Korhaz Nonprofit Kft
Phase III Study Comparing the Efficacy and Safety of EP2006 and Filgrastim
Italy
Torino : Azienda Ospedaliero Universitaria "San Giovanni Battista di Torino"
Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor
Japan
Nagoya : Nagoya University Graduate School of Medicine
Comparing Ciprofloxacin (CPFX) With Cefepime (CFPM) in Febrile Neutropenic Patients With Hematologic Diseases
Korea, Republic of
Busan :
Micafungin Prevention Study for Fungal Disease in Child Receiving Allogenic Hematopoietic Stem Cell Transplantation
Daegu :
Micafungin Prevention Study for Fungal Disease in Child Receiving Allogenic Hematopoietic Stem Cell Transplantation
Daejeon :
Micafungin Prevention Study for Fungal Disease in Child Receiving Allogenic Hematopoietic Stem Cell Transplantation
Goyang :
Micafungin Prevention Study for Fungal Disease in Child Receiving Allogenic Hematopoietic Stem Cell Transplantation
Hwasun :
Micafungin Prevention Study for Fungal Disease in Child Receiving Allogenic Hematopoietic Stem Cell Transplantation
View More »
Seoul :
Micafungin Prevention Study for Fungal Disease in Child Receiving Allogenic Hematopoietic Stem Cell Transplantation
Seoul : Korea University GURO hospital
Phase III Study of DA-3031(PEG-G-CSF) in Chemotherapy-induced Neutropenia
Suwon :
Micafungin Prevention Study for Fungal Disease in Child Receiving Allogenic Hematopoietic Stem Cell Transplantation
Latvia
Daugavpils : Daugavpils Regional Hospital
Phase III Study Comparing the Efficacy and Safety of EP2006 and Filgrastim
Poland
Bydgoszcz :
Evaluation of Maxy-G34 in Breast Cancer Patients Treated With TAC (Docetaxel, Adriamycin, Cyclophosphamide) Chemotherapy
Gdansk :
Evaluation of Maxy-G34 in Breast Cancer Patients Treated With TAC (Docetaxel, Adriamycin, Cyclophosphamide) Chemotherapy
Lublin :
Evaluation of Maxy-G34 in Breast Cancer Patients Treated With TAC (Docetaxel, Adriamycin, Cyclophosphamide) Chemotherapy
Lublin : SPSK1 Klinika Hematologii
Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor
Romania
Bucuresti : Centrul de Diagnostic si Tratament Euromedic Fundeni
Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor
Jud. Bacau :
Evaluation of Maxy-G34 in Breast Cancer Patients Treated With TAC (Docetaxel, Adriamycin, Cyclophosphamide) Chemotherapy
Suceava :
Evaluation of Maxy-G34 in Breast Cancer Patients Treated With TAC (Docetaxel, Adriamycin, Cyclophosphamide) Chemotherapy
Timisoara :
Evaluation of Maxy-G34 in Breast Cancer Patients Treated With TAC (Docetaxel, Adriamycin, Cyclophosphamide) Chemotherapy
Russian Federation
Chelyabinsk : State Medical-Prophylactic Institution SMPI Reginal Clinical Oncological Dispensary
Phase III Study Comparing the Efficacy and Safety of EP2006 and Filgrastim
Magnitogorsk : State Healthcare Institution SHI Regional Oncological Dispensary
Phase III Study Comparing the Efficacy and Safety of EP2006 and Filgrastim
Moscow Area :
Evaluation of Maxy-G34 in Breast Cancer Patients Treated With TAC (Docetaxel, Adriamycin, Cyclophosphamide) Chemotherapy
Pyatigorsk : State Healthcare Institution SHI Pyatigorsk Oncological Dispensary
Phase III Study Comparing the Efficacy and Safety of EP2006 and Filgrastim
Saint-Petersburg : Non-State Healthcare Institution NSHI
Phase III Study Comparing the Efficacy and Safety of EP2006 and Filgrastim
Slovakia
Kosice : Oddelenie klinickej onkologie, Vyvhodoslovensky onkologicky ustav
Phase III Study Comparing the Efficacy and Safety of EP2006 and Filgrastim
Spain
Barcelona : Hospital Clinic i Provincial de Barcelona
Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor
Switzerland
Genolier : IMO Clinique de Genolier
Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor
Ukraine
Dnipropetrovsk :
Evaluation of Maxy-G34 in Breast Cancer Patients Treated With TAC (Docetaxel, Adriamycin, Cyclophosphamide) Chemotherapy
Uzhorod :
Evaluation of Maxy-G34 in Breast Cancer Patients Treated With TAC (Docetaxel, Adriamycin, Cyclophosphamide) Chemotherapy
United Kingdom
Rotherham : The Rotherham NHS Foundation Trust - Dept. of Haematology
Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor
